Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

Shiva Rajkumar, who last month underwent bladder cancer surgery in the US, is back in his hometown of Bengaluru, where he met ...

They have made tremendous sacrifices for our country and wore the uniform proudly. We are talking about our military veterans ...

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Some patients with low-grade Ta nonmuscle-invasive bladder cancer (LG Ta NMIBC) can experience recurrence after many years.

Incorporating mpMRI into initial staging before TURBT reduces the time to correct treatment for patients with MIBC.

TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the resear ...